Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent

Objective: This study compared sirolimus-eluting stents (SES) with everolimus-eluting stents (EES) in coronary artery disease patients. Methods: A total of 1,174 patients were enrolled in the study; 290 patients (25.28%) were treated with EES and 884 patients (74.72%) were treated with SES. The t...

Full description

Bibliographic Details
Main Authors: Marc Silvestri, Manjunath Cholenahally Nanjappa, Rame Gowda Raghu, Rajagopal Jambu-nathan
Format: Article
Language:English
Published: European Medical Journal 2018-09-01
Series:European Medical Journal
Subjects:
definite stent thrombosis (dst)
drug-eluting stent (des)
everolimus-eluting stents (ees)
outcome
percutaneous coronary intervention (pci)
prism
sirolimus-eluting stents (ses)
real-world trial
Online Access:https://www.emjreviews.com/interventional-cardiology/article/interim-results-of-the-basket-of-real-world-randomised-clinical-prism-trials-for-msure-s-a-next-generation-sirolimus-eluting-stent-versus-eliminator-an-everolimus-eluting-stent/

Internet

https://www.emjreviews.com/interventional-cardiology/article/interim-results-of-the-basket-of-real-world-randomised-clinical-prism-trials-for-msure-s-a-next-generation-sirolimus-eluting-stent-versus-eliminator-an-everolimus-eluting-stent/

Similar Items